Increased inflammasome protein expression and Gal-3 have been associated with common comorbidities of NASH, such as hypertension, obesity, and type 2 diabetes, making it difficult to correlate these potential biomarkers with NASH exclusively [1,20,46]. This evidence concerns the gene LGALS3 and type 2 diabetes mellitus.